Check out the latest news from Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma, was invited to present the company's latest updates and the development of linaprazan glurate at the Redeye Investor Forum Online on September 19th, 2024.
Read more
Christer Ahlberg, CEO of Cinclus Pharma, will present the company's latest updates and the development of linaprazan glurate at Redeye Investor Forum Online on September 19th.
Read more
Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of the drug candidate linaprazan glurate, held by CEO Christer Ahlberg at Aktiespararnas event September 17th.
Read more